Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-01-29 @ 9:21 AM
Study NCT ID:
NCT02158520
Status:
COMPLETED
Last Update Posted:
2020-01-21
First Post:
2014-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery
Sponsor:
Academic and Community Cancer Research United
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-18
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-30
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-05
First Submit QC Date:
None
Study First Post Date:
2014-06-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-11-21
Results First Submit QC Date:
None
Results First Post Date:
2020-01-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-07
Last Update Post Date:
2020-01-21
Last Update Post Date Type:
ACTUAL